Brain-heart Interactions in Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: (BRAINHEART)
Takotsubo Cardiomyopathy, Cardiac X Syndrome, Acute Myocardial Infarction
About this trial
This is an interventional other trial for Takotsubo Cardiomyopathy
Eligibility Criteria
Inclusion Criteria:
- Group A. 15 patients with Cardiac X Syndrome (CSX), according to the diagnostic criteria previously proposed by Lanza et al.
- Group B. 15 patients with Tako-Tsubo Cardiomyopathy (TTC), according to Mayo diagnostic criteria at least 6 months after being hospitalized or diagnosed with TTC.
- Group C (control group). 15 prospectively enrolled patients with previous Type 1, 4a, 4b myocardial infarction (ST-segment elevation acute myocardial infarction [STEMI] and Non ST-segment elevation acute myocardial infarction [NSTEMI] acute coronary syndrome [ACS] with significant ≥70% coronary stenosis) at least six months after the event.
Acute myocardial infarction will be defined according to the third universal definition of myocardial infarction.
Exclusion Criteria:
- Refused consent
- Unable to participate or provide written informed consent
- Short-term survival (<1 year)
- Acute or decompensated medical conditions
- Acute neurological or psychiatric diseases
- Absence of sinus rhythm or frequent ectopic beats
- History of severe lung, liver, kidney or autoimmune diseases
- Any contraindication to MRI
Sites / Locations
- Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni Bellinzona
Arms of the Study
Arm 1
Arm 2
Arm 3
Other
Other
Other
Cardiac X Syndrome (CSX)
Takotsubo Cardiomyopathy (TTC)
Acute myocardial infarction (AMI)
patients with Cardiac X Syndrome (CSX), according to the diagnostic criteria previously proposed by Lanza (Lanza, Heart. 2007)
Tako-Tsubo Cardiomyopathy (TTC), according to Mayo diagnostic criteria at least six months after the event. (Prasad A, et al. Am Heart J. 2008)
Type 1, 4a, 4b myocardial infarction (ST-segment elevation acute myocardial infarction [STEMI] and Non ST-segment elevation acute myocardial infarction [NSTEMI] acute coronary syndrome [ACS] with significant ≥70% coronary stenosis) at least six months after the event. (Thygesen K, et al. Eur Heart J. 2012)